Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
follitropin epsilon
- Development stage
- Approved
- Lead developer
- Pentixapharm
- Modality
- Recombinant Proteins and Enzymes
- Administration
- Subcutaneous
01
Overview
Follitropin epsilon is a fully human, glyco-optimized recombinant follicle-stimulating hormone (FSH) developed for ovarian stimulation in assisted reproductive technologies such as in vitro fertilization. Unlike other recombinant FSH products produced in Chinese hamster ovary (CHO) or human fetal retinal cells, follitropin epsilon is manufactured using a human blood cell line derived from a myeloid leukemia cell line, resulting in unique glycosylation patterns that may affect its pharmacodynamics and potency. It acts by binding to the follicle-stimulating hormone receptor on ovarian follicles, stimulating their growth and maturation. Clinical studies have shown that follitropin epsilon can induce similar or greater ovarian responses compared to standard doses of other r-hFSH products like follitropin alfa[1][3][4][5][6]. The drug has not yet been marketed and remains under clinical investigation.
- Brand names
- FSH GEX
- Other names
- human glyco-optimized recombinant FSHrecombinant FSH
02
Targets
FSHR (Follicle-stimulating hormone receptor)
Beyond the preview
Go deeper on follitropin epsilon.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on follitropin epsilon.